Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhongsheng Haitian Pharmaceutical is a Chinese pharmaceutical company primarily focused on the distribution, marketing, and sales of biological products and medicines. As a subsidiary or closely affiliated entity within the broader Sinopharm (China National Pharmaceutical Group) ecosystem, specifically linked to China National Biotec Group (CNBG), it plays a significant role in the supply chain of vaccines and blood products. The company operates extensively in the domestic Chinese market, providing logistics and professional marketing services for a wide range of therapeutic and prophylactic products. Its business model emphasizes the integration of pharmaceutical R&D results into the commercial market through robust distribution networks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhongsheng Haitian Pharmaceutical.